+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Oncology Market - Global Forecast 2026-2032- Product Image
Artificial Intelligence in Oncology Market - Global Forecast 2026-2032- Product Image
Sale

Artificial Intelligence in Oncology Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055601
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Intelligence in Oncology Market is projected to reach USD 3.14 Billion in 2026. It is expected to continue growing at a CAGR of 15.70%, reaching USD 7.61 Billion by 2032.

Artificial Intelligence Is Reshaping Oncology Across the Care Pathway

Artificial intelligence (AI) is being applied across oncology to support screening, diagnostic imaging, pathology, treatment planning, clinical decision-making, drug discovery, patient monitoring, and operational workflows. Its value depends on the quality and representativeness of clinical data, integration with existing systems, transparent validation, and appropriate human oversight. The field is moving from isolated pilots toward governed use cases embedded in multidisciplinary care.

From Standalone Tools to Integrated, Evidence-Based Oncology Workflows

The oncology landscape is shifting toward multimodal systems that combine imaging, pathology, molecular profiles, clinical records, and longitudinal outcomes. Cloud infrastructure, interoperable data standards, federated learning, and improved computing access are supporting collaboration across institutions while helping address data-sharing constraints. At the same time, regulators and health systems are emphasizing clinical validation, post-deployment monitoring, cybersecurity, explainability, and controls against bias. Adoption is therefore becoming less about technical novelty and more about demonstrable clinical utility and workflow fit.

AI’s Cumulative Impact Depends on Trust, Data Quality, and Clinical Integration

AI can help identify suspicious lesions, quantify tumor characteristics, prioritize cases, support precision treatment selection, and reduce repetitive administrative work. Used responsibly, these capabilities may improve consistency and help clinicians manage growing diagnostic complexity. However, performance can vary across populations, equipment, institutions, and disease subtypes. Data drift, automation bias, privacy risks, unclear accountability, and limited prospective evidence remain material barriers. The cumulative impact will be strongest where AI augments-not replaces-oncologists and is supported by continuous evaluation, clinician training, patient communication, and equitable access.

Regional Readiness Varies Across North America, Europe, and Emerging Ecosystems

North America benefits from advanced research capacity, digital infrastructure, and substantial clinical data networks, while still confronting interoperability, reimbursement, privacy, and validation challenges. Europe is shaped by strong research institutions, cross-border data considerations, and a pronounced emphasis on safety, transparency, and regulatory governance. Asia-Pacific combines advanced technology ecosystems with large and diverse patient populations, but adoption varies with infrastructure, language, data-governance, and health-system capacity. Latin America is expanding digital-health capabilities while facing uneven access to data infrastructure and specialist services. The Middle East is investing in connected healthcare and innovation programs, with implementation dependent on workforce development and governance. Africa presents significant opportunities for AI-enabled screening and service expansion, alongside constraints involving connectivity, data availability, affordability, and local validation.

International Groups Are Aligning Innovation With Health-System Governance

ASEAN countries are exploring collaborative digital-health and research approaches, but differ substantially in infrastructure, regulation, and specialist capacity. BRICS members offer large patient populations and varied research strengths, while data governance, interoperability, and access conditions remain uneven. The European Union is advancing coordinated approaches to trustworthy AI, health-data access, and medical-device oversight. G7 members generally possess mature research and regulatory capabilities, yet must address implementation equity and real-world evidence. GCC states are developing digitally enabled healthcare systems and specialized infrastructure, with emphasis on workforce capability and secure data use. NATO members are also considering resilience, cybersecurity, and trusted technology standards relevant to health systems and biomedical research.

Country Priorities Reflect Distinct Data, Regulation, and Care-Delivery Conditions

Australia is emphasizing digital-health interoperability and geographically inclusive care. Brazil is developing AI and genomics capabilities while addressing regional inequality and data governance. Canada combines strong research capacity with a focus on public-sector accountability, privacy, and equitable implementation. China is advancing medical AI, imaging, and digital infrastructure within a distinct regulatory and data environment. France, Germany, Italy, and Spain are pairing clinical research with European governance requirements and health-system integration priorities. India is applying AI to scale access across a diverse and resource-variable care system. Japan and South Korea bring advanced technology and aging-population considerations to oncology innovation. Mexico is expanding digital-health adoption while facing uneven infrastructure and specialist availability. Russia’s oncology-AI development is influenced by domestic research, data, and health-system conditions. The United Kingdom has strong translational research and evaluation capabilities, with attention to evidence, procurement, and safe deployment. The United States remains a major center for AI research, clinical innovation, and regulatory development, while confronting interoperability, reimbursement, bias, and implementation challenges.

Leaders Should Build Governed, Clinically Validated AI Capabilities

Industry leaders should prioritize high-value use cases with clearly defined clinical outcomes, establish multidisciplinary governance spanning clinicians, data scientists, legal experts, patients, and cybersecurity teams, and validate systems across diverse populations and care settings. They should invest in interoperable data foundations, model monitoring, audit trails, incident reporting, and human-in-the-loop controls. Procurement should require evidence of usability, fairness, security, lifecycle support, and integration costs rather than relying on benchmark performance alone. Partnerships with hospitals, research organizations, regulators, and patient groups can strengthen prospective evidence and trust. Workforce programs should ensure clinicians understand model limitations, while implementation plans should include access safeguards so AI does not widen disparities.

Methodology Combines Structured Evidence Review With Cross-Market Synthesis

This executive summary uses a structured synthesis of publicly available, verifiable evidence relevant to AI in oncology, including peer-reviewed research, regulatory materials, clinical guidance, health-system documentation, standards, and official policy sources. Findings are organized by technology shift, clinical application, governance issue, region, international group, and country. The assessment distinguishes demonstrated capabilities from emerging applications and highlights factors that influence safe adoption, including data quality, validation, interoperability, infrastructure, workforce readiness, privacy, and equity. Because implementation conditions change rapidly, individual tools and policies should be reassessed against current regulatory status and prospective clinical evidence.

Responsible Integration Will Determine Oncology AI’s Long-Term Value

AI is becoming an important enabling layer in oncology, but its contribution will be determined by clinical evidence, trustworthy governance, practical integration, and equitable access. The most durable progress will come from solutions that solve well-defined care problems, complement professional judgment, and remain measurable after deployment. Organizations that combine technical capability with rigorous validation, patient-centered design, and accountable oversight will be better positioned to translate AI advances into safer and more effective oncology care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Intelligence in Oncology Market, by Product Type
7.1. Introduction
7.2. Hardware
7.2.1. Diagnostic Imaging Systems
7.2.2. Robotic Surgical Systems
7.3. Services
7.3.1. Consulting Services
7.3.2. Implementation Services
7.4. Software Solutions
8. Artificial Intelligence in Oncology Market, by Technology
8.1. Introduction
8.2. Computer Vision
8.3. Deep Learning
8.4. Machine Learning
8.5. Natural Language Processing
9. Artificial Intelligence in Oncology Market, by Cancer Type
9.1. Introduction
9.2. Breast Cancer
9.3. Cervical Cancer
9.4. Colorectal Cancer
9.5. Esophageal Cancer
9.6. Liver Cancer
9.7. Lung Cancer
9.8. Skin Cancer
9.9. Stomach (Gastric) Cancer
9.10. Thyroid Cancer
10. Artificial Intelligence in Oncology Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Imaging Analytics
10.2.2. Molecular Diagnostics
10.2.3. Pathology
10.3. Drug Discovery
10.3.1. Clinical Trials Design
10.3.2. Lead Discovery
10.3.3. Target Identification
10.4. Outcome Prediction
10.4.1. Complication Prediction
10.4.2. Response Prediction
10.4.3. Survival Rate Visualization
10.5. Personalized Medicine
10.5.1. Biomarker Identification
10.5.2. Genomic Data Analysis
10.5.3. Therapeutic Optimization
10.6. Treatment Planning
10.6.1. Chemotherapy Planning
10.6.2. Surgical Planning
11. Artificial Intelligence in Oncology Market, by End User
11.1. Introduction
11.2. Diagnostic Centers
11.3. Hospitals & Clinics
11.4. Pharma & Biotech Companies
11.5. Research Institutes & Organizations
12. Artificial Intelligence in Oncology Market, by Deployment Mode
12.1. Introduction
12.2. Cloud
12.3. On Premise
13. Artificial Intelligence in Oncology Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Artificial Intelligence in Oncology Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Artificial Intelligence in Oncology Market, by Country
15.1. Introduction
15.2. United States
15.3. China
15.4. Germany
15.5. Japan
15.6. India
15.7. United Kingdom
15.8. France
15.9. Italy
15.10. Brazil
15.11. Canada
15.12. Mexico
15.13. Russia
15.14. Spain
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Amazon Web Services, Inc.
17.2. AstraZeneca PLC
17.3. Azra AI
17.4. Bayer AG
17.5. BPGbio, Inc.
17.6. Bristol-Myers Squibb Company
17.7. Butterfly Network, Inc.
17.8. ConcertAI LLC
17.9. Elekta AB
17.10. F. Hoffmann-La Roche Ltd.
17.11. Flatiron Health, Inc.
17.12. Freenome Holdings, Inc.
17.13. GE Healthcare
17.14. Google LLC by Alphabet Inc.
17.15. Intel Corporation
17.16. International Business Machines Corporation
17.17. Koninklijke Philips N.V.
17.18. Lunit Inc.
17.19. Medial EarlySign Ltd.
17.20. Microsoft Corporation
17.21. Novartis AG
17.22. NVIDIA Corporation
17.23. Oncora Medical, Inc.
17.24. Paige.AI Inc.
17.25. Panakeia Technologies LTD
17.26. PathAI, Inc.
17.27. Rakovina Therapeutics Inc.
17.28. Siemens Healthineers AG
17.29. Tempus AI, Inc.
17.30. Ultromics Limited
17.31. Viz.ai, Inc.
17.32. Zebra Medical
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Artificial Intelligence in Oncology Market, Years Considered for the Study
FIGURE 2. Global Artificial Intelligence in Oncology Market, Research Design
FIGURE 3. Global Artificial Intelligence in Oncology Market, Research Framework
FIGURE 4. Global Artificial Intelligence in Oncology Market, Data Triangulation
FIGURE 5. Global Artificial Intelligence in Oncology Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Artificial Intelligence in Oncology Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Artificial Intelligence in Oncology Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Artificial Intelligence in Oncology Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Artificial Intelligence in Oncology Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Artificial Intelligence in Oncology Market Size, by Cancer Type, 2025 vs 2032 (%)
FIGURE 11. Global Artificial Intelligence in Oncology Market Size, by Cancer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Artificial Intelligence in Oncology Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Artificial Intelligence in Oncology Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Artificial Intelligence in Oncology Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Artificial Intelligence in Oncology Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2025 vs 2032 (%)
FIGURE 17. Global Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Artificial Intelligence in Oncology Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Artificial Intelligence in Oncology Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Artificial Intelligence in Oncology Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Artificial Intelligence in Oncology Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Artificial Intelligence in Oncology Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Artificial Intelligence in Oncology Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Artificial Intelligence in Oncology Market Segmentation & Coverage
TABLE 2. Global Artificial Intelligence in Oncology Market Size, 2017-2032 (USD Million)
TABLE 3. Global Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Hardware Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Hardware Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Hardware Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Diagnostic Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Diagnostic Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Diagnostic Imaging Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Robotic Surgical Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Robotic Surgical Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Robotic Surgical Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Consulting Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Consulting Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Consulting Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Implementation Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Implementation Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Implementation Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Software Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Software Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Software Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 26. Global Computer Vision Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Computer Vision Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Computer Vision Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Deep Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Deep Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Deep Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Machine Learning Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Machine Learning Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Machine Learning Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Natural Language Processing Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Natural Language Processing Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Natural Language Processing Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 39. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Cervical Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Cervical Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Cervical Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Colorectal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Colorectal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Colorectal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Esophageal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Esophageal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Esophageal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Liver Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Liver Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Liver Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Skin Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Skin Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Skin Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Stomach (Gastric) Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Stomach (Gastric) Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Stomach (Gastric) Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Thyroid Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Thyroid Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Thyroid Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 67. Global Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Imaging Analytics Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Imaging Analytics Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Imaging Analytics Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Pathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Clinical Trials Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Clinical Trials Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Clinical Trials Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Lead Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Lead Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Lead Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Target Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Target Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Target Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Outcome Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Outcome Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Outcome Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Complication Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Complication Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Complication Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Response Prediction Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Response Prediction Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Response Prediction Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Survival Rate Visualization Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Survival Rate Visualization Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Survival Rate Visualization Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Biomarker Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Biomarker Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Biomarker Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Genomic Data Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Genomic Data Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Genomic Data Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Therapeutic Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Therapeutic Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Therapeutic Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Treatment Planning Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Treatment Planning Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Treatment Planning Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Chemotherapy Planning Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Chemotherapy Planning Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Chemotherapy Planning Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Surgical Planning Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Surgical Planning Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Surgical Planning Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Pharma & Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Pharma & Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Pharma & Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Research Institutes & Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Research Institutes & Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Research Institutes & Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 138. Global Cloud Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Cloud Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Cloud Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global On Premise Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global On Premise Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global On Premise Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Artificial Intelligence in Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 159. North America Artificial Intelligence in Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. North America Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. North America Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 162. North America Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 163. North America Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. North America Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 165. North America Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. North America Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 167. North America Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 168. North America Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 169. North America Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 170. North America Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 171. North America Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. North America Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 173. Latin America Artificial Intelligence in Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Latin America Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. Latin America Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 176. Latin America Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 177. Latin America Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 178. Latin America Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 179. Latin America Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Latin America Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 181. Latin America Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 182. Latin America Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 183. Latin America Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 184. Latin America Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 185. Latin America Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Latin America Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 187. Europe Artificial Intelligence in Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Europe Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. Europe Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 190. Europe Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 191. Europe Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. Europe Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 193. Europe Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 194. Europe Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 195. Europe Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 196. Europe Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 197. Europe Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 198. Europe Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 199. Europe Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Europe Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 201. Middle East Artificial Intelligence in Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Middle East Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Middle East Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 204. Middle East Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 205. Middle East Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 206. Middle East Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 207. Middle East Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Middle East Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 209. Middle East Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 210. Middle East Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 211. Middle East Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 212. Middle East Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 213. Middle East Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Middle East Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 215. Africa Artificial Intelligence in Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. Africa Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. Africa Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 218. Africa Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 219. Africa Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 220. Africa Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 221. Africa Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Africa Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 223. Africa Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 224. Africa Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 225. Africa Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 226. Africa Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 227. Africa Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Africa Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 229. Global Artificial Intelligence in Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. ASEAN Artificial Intelligence in Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 231. ASEAN Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 232. ASEAN Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 233. ASEAN Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 234. ASEAN Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. ASEAN Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 236. ASEAN Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. ASEAN Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 238. ASEAN Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 239. ASEAN Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 240. ASEAN Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 241. ASEAN Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 242. ASEAN Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. ASEAN Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 244. GCC Artificial Intelligence in Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 245. GCC Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. GCC Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 247. GCC Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 248. GCC Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. GCC Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 250. GCC Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. GCC Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 252. GCC Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 253. GCC Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 254. GCC Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 255. GCC Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 256. GCC Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. GCC Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 258. European Union Artificial Intelligence in Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. European Union Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. European Union Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 261. European Union Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 262. European Union Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 263. European Union Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 264. European Union Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 265. European Union Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 266. European Union Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 267. European Union Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 268. European Union Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 269. European Union Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 270. European Union Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. European Union Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 272. BRICS Artificial Intelligence in Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 273. BRICS Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. BRICS Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 275. BRICS Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 276. BRICS Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. BRICS Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 278. BRICS Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. BRICS Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 280. BRICS Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 281. BRICS Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 282. BRICS Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 283. BRICS Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 284. BRICS Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. BRICS Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 286. G7 Artificial Intelligence in Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 287. G7 Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. G7 Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 289. G7 Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 290. G7 Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 291. G7 Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 292. G7 Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. G7 Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 294. G7 Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 295. G7 Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 296. G7 Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 297. G7 Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 298. G7 Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. G7 Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 300. NATO Artificial Intelligence in Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 301. NATO Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 302. NATO Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 303. NATO Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 304. NATO Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 305. NATO Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 306. NATO Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. NATO Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 308. NATO Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 309. NATO Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 310. NATO Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 311. NATO Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 312. NATO Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. NATO Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 314. Global Artificial Intelligence in Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 315. United States Artificial Intelligence in Oncology Market Size, 2017-2032 (USD Million)
TABLE 316. United States Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 317. United States Artificial Intelligence in Oncology Market Size, by Hardware, 2017-2032 (USD Million)
TABLE 318. United States Artificial Intelligence in Oncology Market Size, by Services, 2017-2032 (USD Million)
TABLE 319. United States Artificial Intelligence in Oncology Market Size, by Technology, 2017-2032 (USD Million)
TABLE 320. United States Artificial Intelligence in Oncology Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 321. United States Artificial Intelligence in Oncology Market Size, by Application, 2017-2032 (USD Million)
TABLE 322. United States Artificial Intelligence in Oncology Market Size, by Diagnostics, 2017-2032 (USD Million)
TABLE 323. United States Artificial Intelligence in Oncology Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 324. United States Artificial Intelligence in Oncology Market Size, by Outcome Prediction, 2017-2032 (USD Million)
TABLE 325. United States Artificial Intelligence in Oncology Market Size, by Personalized Medicine, 2017-2032 (USD Million)
TABLE 326. United States Artificial Intelligence in Oncology Market Size, by Treatment Planning, 2017-2032 (USD Million)
TABLE 327. United States Artificial Intelligence in Oncology Market Size, by End User, 2017-2032 (USD Million)
TABLE 328. United States Artificial Intelligence in Oncology Market Size, by Deployment Mode, 2017-2032 (USD Million)
TABLE 329. China Artificial Intelligence in Oncology Market Size, 2017-2032 (USD Million)
TABLE 330. China Artificial Intelligence in Oncology Market Size, by Product Type, 2017-2032 (USD Million)
TABL

Companies Mentioned

  • Amazon Web Services, Inc.
  • AstraZeneca PLC
  • Azra AI
  • Bayer AG
  • BPGbio, Inc.
  • Bristol-Myers Squibb Company
  • Butterfly Network, Inc.
  • ConcertAI LLC
  • Elekta AB
  • F. Hoffmann-La Roche Ltd.
  • Flatiron Health, Inc.
  • Freenome Holdings, Inc.
  • GE Healthcare
  • Google LLC by Alphabet Inc.
  • Intel Corporation
  • International Business Machines Corporation
  • Koninklijke Philips N.V.
  • Lunit Inc.
  • Medial EarlySign Ltd.
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Oncora Medical, Inc.
  • Paige.AI Inc.
  • Panakeia Technologies LTD
  • PathAI, Inc.
  • Rakovina Therapeutics Inc.
  • Siemens Healthineers AG
  • Tempus AI, Inc.
  • Ultromics Limited
  • Viz.ai, Inc.
  • Zebra Medical

Related Topics

Related Reports

Artificial Intelligence Market Global Report by Solution, Technology, End-User, Countries and Company Analysis 2026-2034 - Product Image

Artificial Intelligence Market Global Report by Solution, Technology, End-User, Countries and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
United States Artificial Intelligence Market Report and Forecast 2025-2034 - Product Image

United States Artificial Intelligence Market Report and Forecast 2025-2034

  • Report
  • 135 Pages
  • United States
From
North America Artificial Intelligence Market, By Country, Competition, Forecast, and Opportunities, 2019-2029F - Product Image

North America Artificial Intelligence Market, By Country, Competition, Forecast, and Opportunities, 2019-2029F

  • Report
  • 132 Pages
  • North America
From
Artificial Intelligence (AI) and Immersive Virtual Worlds: Intellectual Property (IP) and standards and policies (November 4, 2027) - Product Image

Artificial Intelligence (AI) and Immersive Virtual Worlds: Intellectual Property (IP) and standards and policies (November 4, 2027)

  • Training
  • 1 Day
  • Global
Immuno-Oncology Market - Global Forecast 2026-2032 - Product Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.